α1-Antitrypsin Augmentation Therapy

This publication has 10 references indexed in Scilit:

• Pharmacokinetic Study of α1-Antitrypsin Infusion in α1-Antitrypsin Deficiency
  Chest, 1997
• The intrapulmonary half-life and safety of aerosolized alpha1-protease inhibitor in normal volunteers.
  American Journal of Respiratory and Critical Care Medicine, 1997
• Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group.
  American Journal of Respiratory and Critical Care Medicine, 1996
• Opportunities for the Use of Aerosolized α1-Antitrypsin for the Treatment of Cystic Fibrosis
  Chest, 1996
• The proteinase-antiproteinase balance in alpha-1-proteinase inhibitor-deficient lung transplant recipients.
  American Journal of Respiratory and Critical Care Medicine, 1994
• Aerosol α1 -antitrypsin treatment for cystic fibrosis
  The Lancet, 1991
• Strategies for aerosol therapy ofα 1-antitrypsin deficiency by the aerosol route
  Lung, 1990
• Anti-Neutrophil-Elastase Defenses of the Lower Respiratory Tract in α1-Antitrypsin Deficiency Directly Augmented with an Aerosol of α1-Antitrypsin
  Annals of Internal Medicine, 1989
• Replacement Therapy for Alpha₁-Antitrypsin Deficiency Associated with Emphysema
  New England Journal of Medicine, 1987
• Natural History and Life Expectancy in Severe Alpha₁‐Antitrypsin Deficiency, Pi Z
  Acta Medica Scandinavica, 1978